This is the authors' abstract. We don't add key points for this paper.
In 2013, a novel thermally dimorphic fungal pathogen was described to cause disseminated disease among persons living with advanced HIV/AIDS in South Africa. Although the organism was initially described as an Emmonsia-like fungus, it is now known to belong to a new genus of thermally dimorphic fungi and was recently named Emergomyces africanus. There is considerable clinical and histopathological overlap between emergomycosis and histoplasmosis. This review addresses taxonomic, clinical, diagnostic, and therapeutic aspects of Es. africanus disease, a condition which has, to date, only been reported from southern Africa.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Govender et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: